<DOC>
	<DOCNO>NCT02141672</DOCNO>
	<brief_summary>To assess efficacy 2 dos voclosporin compare placebo achieve complete remission 24 week therapy subject active lupus nephritis .</brief_summary>
	<brief_title>AURA-LV : Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin ( AURA )</brief_title>
	<detailed_description>Voclosporin next generation CNI intend use prevention organ graft rejection treatment autoimmune disease . The aim current study investigate whether voclosporin add standard care treatment active LN able reduce disease activity , measure reduction proteinuria . Two dos voclosporin study compare placebo control trial background MMF corticosteroid . Patients active , flare LN eligible enter study . They require diagnosis LN accord establish diagnostic criterion ( American College Rheumatology ) clinical biopsy feature suggestive active nephritis . Efficacy assessed ability drug combination reduce level proteinuria demonstrate acceptable safety profile .</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Male female subject age 18 75 year . Diagnosis systemic lupus erythematosus ( SLE ) accord American College Rheumatology criterion . Kidney biopsy within 6 month prior Screening ( Visit 1 ) histologic diagnosis lupus nephritis ( International Society Nephrology/Renal Pathology Society 2003 classification lupus nephritis ) Classes III , IVS IVG , ( A ) ( A/C ) ; Class V , alone combination Class III IV . Laboratory evidence active nephritis screening , define : Class III , IVS IVG : Confirmed proteinuria ≥1,500 mg/24 hour assess 24 hour urine collection , define UPCR ≥1.5 mg/mg assess first morning void urine specimen ( 2 sample ) . Class V ( alone combination Class III IV ) : Confirmed proteinuria ≥2,000 mg/24 hour assess 24 hour urine collection , define UPCR ≥2 mg/mg assess first morning void urine specimen ( 2 sample ) . Estimated glomerular filtration rate ( eGFR ) calculate Chronic Kidney Disease Epidemiology Collaboration equation ≤45 mL/min/1.73 m2 . Currently require renal dialysis ( hemodialysis peritoneal dialysis ) expect require dialysis study period . A previous kidney transplant plan transplant within study treatment period . In opinion Investigator , subject require longterm immunosuppressive treatment ( addition corticosteroid ) . Current medical history : Pancreatitis gastrointestinal hemorrhage within 6 month prior screen . Active unhealed peptic ulcer within 3 month prior screen . If ulcer heal subject adequate therapy , subject may randomize . Congenital acquire immunodeficiency . Clinically significant drug alcohol abuse 2 year prior screen . Malignancy within 5 year screen , exception basal squamous cell carcinoma treat complete excision . Subjects cervical dysplasia cervical intraepithelial neoplasia 1 , treat conization loop electrosurgical excision procedure , normal repeat PAP allow . Lymphoproliferative disease previous total lymphoid irradiation . Severe viral infection ( CMV , HBV , HCV ) within 3 month screen ; know human immunodeficiency virus infection . Active tuberculosis ( TB ) , know history TB/evidence old TB take prophylaxis isoniazid . Other know clinically significant active medical condition , : Severe cardiovascular disease include congestive heart failure , history cardiac dysrhythmia congenital long QT syndrome . Liver dysfunction ( aspartate aminotransferase , alanine aminotransferase , bilirubin great 2.5 time upper limit normal ) screening confirm randomization . Chronic obstructive pulmonary disease asthma require oral steroid . Bone marrow insufficiency unrelated active SLE ( accord Investigator judgment ) white blood cell count &lt; 2,500/mm3 ; absolute neutrophil count &lt; 1.3 x 103/μL ; thrombocytopenia ( platelet count &lt; 50,000/mm3 ) . Active bleeding disorder . Current infection require IV antibiotic . Any overlap autoimmune condition condition treatment condition may affect study assessment outcomes . Overlapping condition condition treatment expect affect assessment outcomes exclude . Subjects pregnant , breast feeding , childbearing potential , use adequate contraceptive precaution .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>lupus nephritis</keyword>
	<keyword>calcineurin inhibitor</keyword>
	<keyword>voclosporin</keyword>
</DOC>